For the third year running DDW is organising a series of seminars at SLAS International Conference and Exhibition. Based on the SLAS2026 theme of Catalyze Discovery, these will be available to visitors of SLAS2026 (7-11 February 2026, Boston, USA).

This programme, Creating Cures: The role of lab automation in successful drug discovery at SLAS2026 - will highlight innovative research using technology in drug development and will be held in the Ignite Theater on 9 and 10 February.

Speakers confirmed:

• Mel Leveridge, Vice President, Assays, Profiling & Cell Sciences, Astra Zeneca: The Role of Automation in Discovery at AstraZeneca
• Mike Ouren, Director of Business Development, Brooks Automation: Top 5 Challenges to Consider When Automating Drug Discovery Lab Workflows
• Kelly Bachovchin PhD, Customer Engagement Scientist, Collaborative Drug Discovery: Interoperable Automation: Real-Time Dataflows to Close DMTA Cycles
• James Pena, Director, Product Management - Digital Science & Automation Solutions, Thermo Fisher Scientific: From Data to Decisions: Digital-Ready Laboratories Powered by Automation
• Dr. Gabe Musso, Chief Scientific Officer, Lunai BioworksDe-Risking the Translation Gap: Coupling AI with High-Throughput In Vivo Models

• Dr. Preeti Ashok, Head of Cell Biology (Novoheart), Medera: From Animal Models to Human Mini-Hearts: How Automated Human-Based Testing is Revolutionizing Drug Discovery.